Data collected from a cohort of complement inhibitor-naive patients with PNH in study 301 were used for this post hoc analysis, to better illustrate the treatment effect of C5 inhibitors on PROs. This evidence concerns the gene C5 and paroxysmal nocturnal hemoglobinuria.